Rapid, cost-effective, sensitive and quantitative detection of Acinetobacter baumannii from pneumonia patients

Iranian Journal of Microbiology

Volumn 3, Issue 4, 2011, Pages 162-169

  Nomanpour, B ^a   Ghodousi, A ^a   Babaei, A ^b   Abtahi, Hr ^a   Tabrizi, M ^a   Feizabadi, M M ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acinetobacter baumannii; HAP; Pneumonia; Real time PCR; VAP

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BODY TEMPERATURE; COLONY FORMING UNIT; COST EFFECTIVENESS ANALYSIS; ESCHERICHIA COLI; HUMAN; IRAN; KLEBSIELLA PNEUMONIAE; LEUKOCYTOSIS; LEUKOPENIA; NONHUMAN; PNEUMONIA; PREDICTIVE VALUE; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; THORAX RADIOGRAPHY;

ACINETOBACTER BAUMANNII; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS;

EID: 84858848281     PISSN: 20083289     EISSN: 20084447     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kollef MH. Review of recent clinical trials of hospital-acquired pneumonia and ventilator associated pneumonia: a perspective from academia. Clin Infect Dis 2010; 1: 51 (Suppl 1) S29-35.
2. Giamarellou H, Antoniadou A, Kanellakopoulou K. Acinetobacter baumannii: a universal threat to public health? Int J Antimicrob Agents 2008; 32: 106-119.
3. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-582.
4. Rungruanghiranya S, Somboonwit C, Kanchanapoom T. Acinetobacter Infection in the Intensive Care Unit. J Infect Dis Antimicrob Agents 2005; 22: 77-92.
5. Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis 2010; 23: 332-339.
6. Perez F, Endimiani A, Bonomo RA. Why are we afraid of Acinetobacter baumannii? Expert Rev Anti Infect Ther 2008; 6: 269-271.
7. Rice LB. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 2006; 43(Suppl. 2): S100-S105.
8. Torres A. Implementation of guidelines on hospital- acquired pneumonia: is there a clinical impact on outcome? Chest 2005; 128: 1900-802.
9. Craven DE. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator- associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
10. Huang Q, Hu Q, Li Q. Identification of 8 food-borne pathogens by multicolor combinational probe coding technology in a single real-time PCR. Clin Chem 2007; 53: 1741-1748.
11. Mackay IM. Real-time PCR in the microbiology laboratory. Clin Microbiol Infect 2004; 10: 190-212.
12. Feizabadi MM, Fathollahzadeh B, Taherikalani M, Rasoolinejad M, Sadeghifard N, Aligholi M, et al. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Jpn J Infect Dis 2008; 61: 274-278.
13. Niederman MS. The clinical diagnosis of ventilator- associated pneumonia. Respir Care 2005; 50: 788-796.
14. Schreckenberger PC, Daneshvar MI, Weyant RS, et al. (2003): Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative Gram-negative rods. In Murray PR, Baron EJ, Jorgensen JA, et al. Manual of Clinical Microbiology (9th ed.). Washington DC: American Society Microbiology. pp. 749-79.
15. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community- acquired pneumonia in adults. Clin Infect Dis 44 (Suppl. 2): S2 -S72.
16. Feizabadi MM, Majnooni A, Nomanpour B, Fatolahzadeh B, Raji N, Delfani S, et al. Direct detection of Pseudomonas aeruginosa from patients with healthcare associated pneumonia by real time PCR. Infect Genet Evol 2010; 10: 1247-1251.
17. Mehndiratta M, Palanichamy JK, Ramalingam P, Pal A, Das P, Sinha S, et al. Fluorescence acquisition during hybridization phase in quantitative real-time PCR improves specificity and signal-to-noise ratio. Biotechniques 2008; 45: 625-626 628, 630 passim.
18. Pfaffl MW. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 2001; 29: e45.
19. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008; 46: 1254-1263.
20. Talbot GH, Bradley J, Edwards JE, Gilbert D, Scheld M, Bartlett JG; Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006; 42: 657-668.
21. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 1-12.
22. Chawla R. Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator associated pneumonia in Asian countries. Am J Infect Control 2008; 36 (4 Suppl): S93-100.
23. Park YK, Peck KR, Cheong HS, Chung DR, Song JH, Ko KS. Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea. Emerg Infect Dis 2009;15: 1325-1327.
24. Davis KA, Moran KA, McAllister CK, Gray PJ. Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis 2005;11: 1218-1224.
25. Keum KC, Yoo SM, Lee SY, Chang KH, Yoo NC, Yoo WM, et al. DNA microarray-based detection of nosocomial pathogenic Pseudomonas aeruginosa and Acinetobacter baumannii. Mol Cell Probes 2006; 20: 42-50.
26. Brown S, Young HK, Amyes SGB. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect 2005; 11: 15-23.
27. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. et al. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 2006; 44: 2974-2976.
28. Guay DR. Guidelines for the management of adults with health care-associated pneumonia: implications for nursing facility residents. Consult Pharm 2006; 21:719-725.
29. Fàbregas N, Ewig S, Torres A, El-Ebiary M, Ramirez J, de La Bellacasa JP, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54: 867-873.
30. Torres A, El-Ebiary M. Bronchoscopic BAL in the diagnosis of ventilator-associated pneumonia. Chest 2000; 117(4 Suppl 2); 198S-202S.
31. Mera RM, Miller LA, Amrine-Madsen H, Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States. Microb Drug Resist 2010; 16: 209-215.